Human Vasodilatory Effect of GLP-1

NHS Foundation Trust

Status: Completed

Conditions: Type2 Diabetes; Angina, Stable; Coronary Stenosis

Treatments: Drug: GLP-1 (7-36)Amide

Study type: Interventional

Funder types: Other

Identifiers

NCT03502083

14/EE/0018

Details and patient eligibility

About

Comprehensive assessment of human vasodilatory effect of GLP-1 in forearm and coronary arteries

Enrollment: 11 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Waiting list for elective PCI to LAD Able to give informed consent Over 18

Exclusion criteria

• GLP-1 based therapy Insulin Calcium channel blockers Nicorandil Nitrates

Trial design

Primary purpose: Basic Science

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)